期刊文献+

p27蛋白和细胞周期素D_1在喉鳞状细胞癌中的表达及意义 被引量:2

Expression of p27 protein and cyclinD_1 in laryngeal carcinoma
原文传递
导出
摘要 目的 :探讨喉癌及癌旁组织中抑癌基因p2 7及癌基因细胞周期素D1的表达状况 ,以及p2 7与细胞周期素D1的表达与喉癌临床特征之间的关系。方法 :用免疫组织化学S P法对 38例喉癌组织 ,癌旁组织进行p2 7及细胞周期素D1检测。结果 :p2 7及细胞周期素D1表达在喉癌和癌旁组织之间各有统计学差异。p2 7及细胞周期素D1表达与颈淋巴结转移和患者预后有相关性 (P <0 .0 5 ) ;且大多数受检喉癌组织中 ,p2 7与细胞周期素D1呈反方向表达。结论 :检测p2 7与细胞周期素D1有助于判断喉癌预后。 Objective:To find out whether the expression of p27 and cyclin D 1 is different in laryngeal squamous cell carcinoma and the edge tissues, and to study the relationship between the expression of p27 and cyclin D 1 with the clinic character in patients with laryngeal squamous cell carcinoma.Method:An immunohistochemistry method was used to study the expression of p27 protein and cyclinD 1 in 38 laryngeal squamous cell carcinoma and the edge tissues.Result:The expression of p27 protein and cyclinD 1 was significantly different between the laryngeal carcinoma and the edge tissue. Low expression of p27 and over expression of cyclinD 1 was associated with the liability of lymph node metastasis and the poor prognosis for patient with laryngeal squamous cell carcinoma. An interesting observation was that the inverse expression between p27 and cyclinD 1 might play an important role in laryngeal squamous cell carcinoma.Conclusion:p27 protein and cyclinD 1 in laryngeal carcinoma is apparently a significance predictor of survival.
出处 《临床耳鼻咽喉科杂志》 CSCD 北大核心 2002年第12期646-647,共2页 Journal of Clinical Otorhinolaryngology
关键词 P27蛋白 细胞周期素D1 喉鳞状细胞癌 表达 免疫组织化学 p27 protein CyclinD 1 Laryngeal carcinoma Immunohistochemistry Cyclin dependent kinase inhibitors
  • 相关文献

参考文献3

  • 1[1]Polak K, Lee M H, Erajument-Bromage H,et al. Cloning of p27 kipl, acyclic-dependent kinase inhibitor and a potential mediator of eX22tracelluar antimitogenic signals. Cell,1994,78:59-66.
  • 2[2]Nakagawa H, Zukerberg L, Togawa K, et al. Human cyclin D1 oncogene and esophageal squalors cell carcinoma. Cancer, 1995,76: 541-549.
  • 3[3]Barkova J,Lukas J,Muller H,et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer, 1994,57:353-361.

同被引文献23

  • 1陈万军,王天铎.鼠抗人单克隆抗体P27^(Kip1)及细胞周期素D1与下咽癌临床关系的研究[J].中华肿瘤杂志,2004,26(6):358-359. 被引量:6
  • 2王俊阁,李晓明,陈英会,路秀英.信号转导和转录激活因子3在喉癌组织中的表达及临床意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(3):113-115. 被引量:17
  • 3ALMADORI G, BUSSU F, CADONI G, et al. Mo- lecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach[J]. Eur J Cancer, 2005,41 : 683 - 693.
  • 4DARNELL J E Jr, KERR I M, STARK G R. Jak- Star pathways and transcriptional activation in re- sponse to IFNs and other extracellular signaling pro- teins [J]. Science, 1994,264: 1415- 1421.
  • 5LIBY K, VOONG N, WILLIAMS C R, et al. The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in mye- loma and lung cancer cells [J]. Clin Cancer Res, 2006,12 : 4288- 4293.
  • 6HUANG S. Regulation of metastases by signal trans- ducer and activator of transcription 3 signaling Path- way: clinical implications[J]. Clin Cancer Res, 2007, 13:1362-1366.
  • 7RAWLINGS J S, ROSLER K M, HARRISON D A. The JAK/STAT signaling pathway[J]. J Cell Sci, 2004,117: 1281- 1283.
  • 8NIU G, WRIGHT K L, HUANG M, et al. Consti- tutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis [J]. Oncogene, 2002, 21: 2000-2008.
  • 9ALVAREZ J V, FEBBO P G, RAMASWAMY S, et al. Identification of genetic signiture of activated STAT3 in human tumors[J]. Cancer Res, 2005, 65: 5054-5062.
  • 10HSIAO J R, JIN Y T, TSAIS T, et al. Constitutive activation of STAT3 and STAT5 is present in the ma- jority of nasopharyngeal carcinoma and correlates with better prognosis[J]. Br J Cancer,2003,89 :344-349.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部